Dehydroacerogenin C exhibits potential in pharmaceutical research due to its structural similarity to bioactive lignans. It has been investigated for cytotoxic properties, showing activity against certain cancer cell lines in vitro. Studies suggest it may interfere with tumor cell proliferation and induce apoptosis, making it a candidate for anticancer drug development. Additionally, it may possess antimicrobial and anti-inflammatory effects, though these applications remain under early-stage evaluation. Its natural origin and complex structure also make it a target for synthetic studies aimed at developing derivatives with enhanced biological activity.